Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach - Tai YK; Chan KKW; Fong CHH; Ramanan S; Yap JLY; Yin JN; Yip YS; Tan WR; Koh APF; Tan NS; Chan CW; Huang RYJ; et al. (Frontiers in Oncology, 2022)
FEMU ID: 47372; EMF-Portal URL: https://www.emf-portal.org/en/article/47372